Candel Therapeutics, Inc. (CADL) vs Olema Pharmaceuticals, Inc. (OLMA)
A side-by-side comparison of Candel Therapeutics, Inc. and Olema Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CADL
Candel Therapeutics, Inc.
$9.97HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
OLMA
Olema Pharmaceuticals, Inc.
$7.92HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
Total return — CADL vs OLMA
growth of $100 · dividends reinvested · last 5yCADL +46.1% (+7.9%/yr)OLMA -64.1% (-18.5%/yr)CADL compounded faster over this window
CADL OLMA
CADL vs OLMA: by the numbers
- •CADL is the larger company ($730M vs $692M market cap).
Metrics side by side
Valuation
| Metric | CADL | OLMA |
|---|---|---|
| P/B ratio | 5.79 | 1.61 |
Profitability
| Metric | CADL | OLMA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -70.19% | -47.51% |
| ROIC | -36.83% | -50.92% |
Growth (annualized)
| Metric | CADL | OLMA |
|---|---|---|
| Total return CAGR (5Y) | -1.42% | -21.50% |
Frequently asked
- How have CADL and OLMA total returns compared?
- Over the past 5 years, CADL delivered -1.42% and OLMA delivered -21.50% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.